^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    DUET-101

    i
    Associations
    News
    Trials
    Company:
    Scopus
    Drug class:
    STAT3 inhibitor, TLR9 agonist
    Related drugs:
    Associations
    News
    Trials